Main > ONCOLOGY (**) > Lung>NSCLC>MET>ALK(+) or ROS1(+) * > Treatment > Co: USA. G. Entrectinib Capsules

---

Co: USA. G. Entrectinib Capsules's subsections
(*) USA Approval Date: 2019. 08.15.
Company
Kinase Inhibitor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 12
Patent>UpDate: 2019. 12.03.
TradeMark
TradeMark Web-Site

Co: USA. G. Entrectinib Capsules's products
This section has no products